Medicine and Dentistry
Multiple Myeloma
100%
Risk Stratification
100%
Hazard Ratio
75%
Progression Free Survival
62%
Antiapoptotic
62%
Diseases
37%
B Cell
25%
Gene Mutation
25%
Cytochrome C
12%
Proportional Hazards Model
12%
Myeloma
12%
Carcinogenesis
12%
Log Rank Test
12%
Single Nucleotide Polymorphism
12%
Disease Course
12%
Scoring System
12%
In Silico
12%
Low Risk Population
12%
Cadherin
12%
Exome Sequencing
12%
Lenalidomide
12%
Neuroscience
Behavior (Neuroscience)
100%
B Cell
100%
Gene Mutation
100%
Cadherin
50%
Carcinogenesis
50%
Cytochrome C
50%
Lenalidomide
50%
Exome Sequencing
50%
Biochemistry, Genetics and Molecular Biology
Progression Free Survival
100%
Genetics
80%
Genomics
60%
B Cell
40%
Gene Mutation
40%
Cadherin
20%
Cytochrome C
20%
Carcinogenesis
20%
Single Nucleotide Polymorphism
20%
Low Risk Population
20%
Exome Sequencing
20%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Antiapoptotic
62%
Progression Free Survival
62%
Diseases
37%
Cytochrome C
12%
Myeloma
12%
Carcinogenesis
12%
Cadherin
12%
Disease Course
12%
Lenalidomide
12%
Immunology and Microbiology
Multiple Myeloma
100%
Progression Free Survival
62%
B Cell
25%
Gene Mutation
25%
Cadherin
12%
Single Nucleotide Polymorphism
12%
Whole Exome Sequencing
12%
Low Risk Population
12%
Lenalidomide
12%
Cytochrome
12%
Keyphrases
Signaling State
44%
Proliferative Signaling
11%
Del(13q)
11%
Revised International Staging System
11%